ASK REDCHAT ANYTHING ABOUT CALCIMEDICA INC.
CalciMedica Inc. (NASDAQ: CALC)
Listen to this Section
$0.59
-0.0073
(
-1.22% )
1.1M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Auxora™DetailsAcute Pancreatitis |
Phase 2b |
| Auxora™DetailsAsparaginase-induced pancreatic toxicity |
Phase 2 |
| Auxora™DetailsAcute Kidney Injury, Kidney disease |
Phase 2 |
| GB-102 (Pan-VEGF inhibitor)DetailsEye disease , Wet age-related macular degeneration , Age-related macular degeneration |
Failed |
| GB-102 (Pan-VEGF inhibitor)DetailsDiabetes, Eye disease , Diabetic macular edema |
Failed |
Market Data
|
| Open |
$0.59 |
| Previous Close |
$0.60 |
| Volume |
1.1M |
| Market Cap |
$9.44M |
| Day Range |
$0.55 - $0.64 |
| 52 Week Range |
$0.46 - $7.20 |
| Shares Outstanding |
15.80M |
| Change % |
-1.22% |
| Net Change |
▼ -0.0073 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-376,293.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-08-25 |
Buy |
3508.00 |
Roberts Eric W |
| 2025-08-21 |
Buy |
9563.00 |
Hebbar Sudarshan |
| 2025-08-21 |
Buy |
1000.00 |
Roberts Eric W |
| 2025-08-21 |
Buy |
9563.00 |
Hebbar Sudarshan |
| 2025-08-19 |
Buy |
5076.00 |
Roberts Eric W |
| 2025-08-18 |
Buy |
1584.00 |
Hebbar Sudarshan |
| 2025-07-23 |
Buy |
1500.00 |
Roberts Eric W |
| 2025-07-23 |
Buy |
1500.00 |
Roberts Eric W |
| 2025-07-22 |
Buy |
1500.00 |
Roberts Eric W |
| 2025-07-21 |
Buy |
1000.00 |
Leheny A. Rachel |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 8-k |
8K-related |
11 |
Mar 18, 2026 |
| 8-k |
8K-related |
12 |
Mar 03, 2026 |
| 10-k |
Annual reports |
102 |
Mar 03, 2026 |
| s-3 |
Registration statements |
20 |
Mar 03, 2026 |